Jacobs Levy Equity Management Inc. bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 6,602 shares of the technology company's stock, valued at approximately $1,386,000.
A number of other institutional investors have also recently added to or reduced their stakes in VEEV. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of Veeva Systems in the 3rd quarter valued at about $26,000. True Wealth Design LLC lifted its holdings in shares of Veeva Systems by 3,375.0% in the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock worth $29,000 after acquiring an additional 135 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Veeva Systems by 3,460.0% in the second quarter. Blue Trust Inc. now owns 178 shares of the technology company's stock worth $33,000 after buying an additional 173 shares during the period. DT Investment Partners LLC bought a new position in shares of Veeva Systems in the second quarter worth approximately $35,000. Finally, Fairscale Capital LLC bought a new position in Veeva Systems in the 2nd quarter worth $46,000. 88.20% of the stock is owned by institutional investors.
Veeva Systems Stock Down 0.6 %
VEEV stock traded down $1.51 during mid-day trading on Monday, hitting $248.94. The company had a trading volume of 1,079,670 shares, compared to its average volume of 973,630. The company has a market capitalization of $40.31 billion, a price-to-earnings ratio of 61.84, a P/E/G ratio of 2.43 and a beta of 0.82. The company has a 50-day moving average price of $218.29 and a 200 day moving average price of $202.83. Veeva Systems Inc. has a 12-month low of $169.98 and a 12-month high of $258.93.
Analyst Upgrades and Downgrades
VEEV has been the topic of a number of research analyst reports. UBS Group increased their price objective on shares of Veeva Systems from $185.00 to $215.00 and gave the company a "neutral" rating in a research report on Monday, August 26th. Barclays upped their price objective on Veeva Systems from $260.00 to $275.00 and gave the company an "overweight" rating in a research report on Friday. Mizuho started coverage on Veeva Systems in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $275.00 target price on the stock. BNP Paribas initiated coverage on shares of Veeva Systems in a research note on Tuesday, October 8th. They issued an "outperform" rating and a $286.00 price objective on the stock. Finally, Truist Financial reissued a "hold" rating and issued a $261.00 price objective (up previously from $207.00) on shares of Veeva Systems in a report on Friday. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eighteen have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $254.04.
Read Our Latest Stock Analysis on Veeva Systems
Insider Buying and Selling
In other Veeva Systems news, SVP Jonathan Faddis sold 1,694 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total transaction of $390,128.20. Following the sale, the senior vice president now owns 8,061 shares of the company's stock, valued at approximately $1,856,448.30. This trade represents a 17.37 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Thomas D. Schwenger sold 1,126 shares of the firm's stock in a transaction on Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the transaction, the insider now directly owns 27,013 shares of the company's stock, valued at approximately $6,483,390.13. This represents a 4.00 % decrease in their position. The disclosure for this sale can be found here. 10.50% of the stock is owned by corporate insiders.
About Veeva Systems
(
Free Report)
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
Before you consider Veeva Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.
While Veeva Systems currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
